Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 4,237,444 |
|
|||||
| News | - | ||||||
| Day High | 5.77 | Low High |
|||||
| Day Low | 5.531 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Novavax Inc | NVAX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.175 | 3.14% | 5.745 | 13:00:11 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 5.62 | 5.531 | 5.77 | 5.57 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 23,080 | 4,237,444 | US$ 5.64 | US$ 23,903,781 | - | 5.30 - 18.55 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 13:00:33 | 158 | US$ 5.745 | USD |
Novavax (NVAX) Options Flow Summary
Novavax Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 673.54M | 118.79M | - | 1.98B | -657.94M | -5.54 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Novavax News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NVAX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.52 | 6.05 | 5.42 | 5.61 | 6,195,968 | 0.225 | 4.08% |
| 1 Month | 6.27 | 6.51 | 5.30 | 5.69 | 5,705,133 | -0.525 | -8.37% |
| 3 Months | 7.77 | 8.15 | 5.30 | 6.69 | 7,246,457 | -2.03 | -26.06% |
| 6 Months | 7.62 | 10.30 | 5.30 | 7.52 | 7,851,186 | -1.88 | -24.61% |
| 1 Year | 16.748 | 18.55 | 5.30 | 8.32 | 7,333,188 | -11.00 | -65.7% |
| 3 Years | 118.80 | 331.5388 | 5.30 | 74.50 | 5,881,039 | -113.06 | -95.16% |
| 5 Years | 44.40 | 331.5388 | 3.54 | 60.40 | 6,180,936 | -38.66 | -87.06% |
Novavax Description
| Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. Novavax develops product candidates geared toward all age demographics of the general population. |
